Navigation Links
Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases
Date:1/6/2011

THOUSAND OAKS, Calif. and MONROVIA, Calif., Jan. 6, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Xencor, Inc. announced today that they will collaborate to develop XmAb®5871, an Fc- engineered monoclonal antibody dually targeting CD19 and CD32b.  XmAb5871 is currently in late-stage preclinical development for the treatment of autoimmune diseases.  

Under the terms of the agreement, Amgen has the option to an exclusive worldwide license following the completion of a pre-defined Phase 2 study.  Xencor will lead all clinical development until that time.  Xencor will receive an up-front and early development milestone payments.  If Amgen does exercise its option, Amgen will assume responsibility for future development, Xencor will receive an option-exercise fee which, combined with the up-front and early development milestones, will total $75 million, and Xencor could receive up to an additional $425 million in clinical, regulatory and commercialization milestone payments.  Xencor will receive tiered royalties on future sales of XmAb5871.

Xencor's CD32b technology is a novel immunomodulatory platform consisting of engineered Fc domains with selective high affinity binding to FcyRIIb (CD32b), a receptor with dominant inhibitory activity on B cells and other immune cells. The CD32b pathway has never been therapeutically exploited and applied to high affinity antibodies targeting immune cells.

"XmAb5871 provides a novel approach to suppress B-cell function which will enhance Amgen's internal efforts in inflammatory diseases," said Joseph P. Miletich, M.D., Ph.D., senior vice president, Research & Development at Amgen.  "We are delighted to have the opportunity to partner with Xencor in exploring their novel immunomodulatory approach."

"Amgen's long-time leadership in antibody development for oncology and i
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Call for Applications: The Amgen Award for Science Teaching Excellence
2. Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits
3. Amgen to Provide Testimony at FDA Hearing on Biosimilars
4. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
5. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
6. Array BioPharma and Amgen Partner in Type 2 Diabetes
7. Amgen to Present at Lazard Capital Healthcare Conference
8. Amgen Announces Webcast of 2009 Third Quarter Financial Results
9. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
10. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... NEW YORK , March 31, 2015 /PRNewswire/ ... biopharmaceutical company advancing protein biologic therapies and oncology ... marketing partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: ... the country,s Ministry of Food and Drug Safety ... (KTR) for MuGard, its oncology supportive-care treatment for ...
(Date:3/31/2015)... 2015 Lighthouse Information Systems, Inc., ... in California, Oregon, Washington and clients across the ... and Acquisition (M&A) Integration Services offering, effective immediately. ... Services and M&A Integration Practice Leader at Lighthouse, ... majority of M&A initiatives fail to achieve their ...
(Date:3/30/2015)... IRVINE, Calif. , March 30, 2015 /PRNewswire/ ... that its subsidiary corporation, NuGene BioPharma, Inc. has ... board. Dr. Guan is an internationally ... After finishing his college education at Peking University, ... his Ph.D. degree from the University of North ...
(Date:3/30/2015)... , March 30, 2015    Intrexon Corporation ... synthetic biology, and Merck Serono, the biopharmaceutical business ... , today announced an exclusive strategic collaboration and ... Receptor T-cell (CAR-T) cancer therapies. This collaboration advances ... therapies that modulate the immune system,s natural ability ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Lighthouse Information Systems, Inc., Announces Addition of M&A Integration Services 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4
... US Oncology, Inc. ,s Fort Worth, Texas ... passed the National Association of Boards of Pharmacy® ( NABP® ) ... on-site inspection. , , ... US Oncology Specialty, a specialty distribution center service of US Oncology, ...
... Genetic ancestry testing is a practice that has ... few years. An estimated half-million Americans will purchase genetic ... worldwide that currently provide this type of service to ... ancestry testing has been accompanied by growing concern about ...
... May 13 /PRNewswire-Asia-FirstCall/ -- China Biologic,Products, Inc. (Nasdaq: CBPO ) ("China ... announced that it will,host a conference call at 8:00 a.m. EDT ... results. , , , ... the call will be Mr. Colin Zhao , Chief Executive Officer, and ...
Cached Biology Technology:US Oncology Continues to Set the Standard as a VAWD(CM) Accredited Wholesale Distributor 2US Oncology Continues to Set the Standard as a VAWD(CM) Accredited Wholesale Distributor 3US Oncology Continues to Set the Standard as a VAWD(CM) Accredited Wholesale Distributor 4US Oncology Continues to Set the Standard as a VAWD(CM) Accredited Wholesale Distributor 5Genetic ancestry testing challenges identified by American Society of Human Genetics task force 2Genetic ancestry testing challenges identified by American Society of Human Genetics task force 3Genetic ancestry testing challenges identified by American Society of Human Genetics task force 4China Biologic Products Schedules Conference Call to Discuss First Quarter 2010 Results 2China Biologic Products Schedules Conference Call to Discuss First Quarter 2010 Results 3
(Date:3/17/2015)... , March 17, 2015 ... company specializing in clinical study management systems, is ... in attendance at ARENA,s Outsourcing in Clinical Trials ... This event provides an excellent forum for MedNet ... flexible and affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/17/2015)... NEW YORK , March 17, 2015 /PRNewswire/ ... , the largest exhibition for service robots ever ... . RoboUniverse takes place on May 11-13, 2015 ... Sponsors and exhibitors for the event include: Acorn ... Motion Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic ...
(Date:3/12/2015)... , March 12, 2015 IriTech, a leading ... member of the Texas Instruments Design Network, announced today ... has demonstrated its IriShield USB MK2120U device during a ... for pension distribution. The iris scanner ... be marketed in India through ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3
... diet, exercise and reduced stress not only can lead to ... new study by a team of researchers, including one from ... The study shows that swallows who maintained a ... were those who produced the most young. The ...
... viruses as they evolved over hundreds of generations to infect ... defences, the viruses evolved at a quicker rate and generated ... to adapt to the viral infection. The study shows, ... Van Valen was correct in his ,Red Queen Hypothesis,. ...
... scientists from the NOAA-funded Gulf of Maine Toxicity (GOMTOX) project ... toxic alga that can cause ,red tides, in the spring ... shellfish industry. An abundant seed population in bottom ... the toxic alga Alexandrium fundyense. This organism swims in ...
Cached Biology News:Study points to role of antioxidant balance in bird health and reproduction 2Study points to role of antioxidant balance in bird health and reproduction 3Scientists reveal driving force behind evolution 2Researchers issue outlook for a significant New England 'red tide' in 2010 2Researchers issue outlook for a significant New England 'red tide' in 2010 3
Request Info...
... FITC is used as the ... tissues or culture cells where the ... It is highly recommended that proper ... primary antibody, be included in experiments ...
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Request Info...
Biology Products: